T4	Material 21 41	embryonic structures
T10	Data 165 195	the serious medical conditions
T13	Process 271 295	the efficient derivation
T23	Method 409 442	the dual-SMAD inhibition strategy
T31	Process 520 542	Concomitant inhibition
T32	Material 621 637	surface ectoderm
T33	Process 581 589	disrupts
T34	Process 613 620	induces
T37	Material 793 811	mature lens fibers
T38	Process 870 885	transplantation
T41	Method 947 954	in vivo
T42	Material 919 946	adrenocorticotropic hormone
T43	Data 669 689	the preplacode stage
T44	Process 698 722	the selective generation
T45	Material 726 760	placode-derived trigeminal ganglia
T53	Process 1095 1121	human cell-based therapies
T57	Material 1208 1221	BMP inhibitor
T58	Process 1239 1245	induce
T59	Material 1265 1270	hESCs
T67	Material 978 1010	a powerful experimental platform
T74	Material 1330 1347	epidermal lineage
T75	Process 1322 1329	induces
T76	Process 1294 1304	suppresses
T80	Method 1400 1408	in vitro
T81	Method 1421 1428	in vivo
T82	Process 1413 1420	engraft
T83	Process 1389 1399	functional
T94	Process 1550 1565	the development
T98	Process 1634 1658	the efficient derivation
T105	Material 1782 1800	trigeminal ganglia
T106	Method 1812 1819	in vivo
T107	Process 1820 1831	engraftment
T114	Process 1076 1091	the development
T118	Method 1921 1928	in vivo
T123	Material 2036 2055	placode derivatives
T124	Process 2059 2080	regenerative medicine
T129	Material 1954 1964	a platform
T130	Process 1969 1977	studying
T131	Process 2020 2032	applications
T132	Process 1893 1902	producing
T5	Material 0 16	Cranial placodes
T1	Process 56 95	sensory and endocrine organ development
T2	Process 97 122	Human placode development
T6	Material 299 315	cranial placodes
T7	Material 321 349	human pluripotent stem cells
T8	Process 351 364	Timed removal
T9	Material 368 392	the BMP inhibitor Noggin
T11	Process 446 462	neural induction
T12	Process 464 472	triggers
T14	Process 473 490	placode induction
T15	Data 509 518	CNS fates
T16	Process 546 580	fibroblast growth factor signaling
T17	Process 590 608	placode derivation
T18	Data 647 665	fate specification
T19	Material 817 859	anterior pituitary hormone-producing cells
T20	Material 894 914	human growth hormone
T21	Process 1020 1053	human cranial placode development
T22	Process 1125 1154	sensory and endocrine disease
T24	Process 1188 1204	Timed withdrawal
T25	Data 1246 1259	placode fates
T26	Process 1273 1293	Timed FGF inhibition
T27	Data 1305 1317	placode fate
T28	Material 1350 1384	Placode-derived trigeminal neurons
T29	Material 1431 1462	Pituitary placode-derived cells
T30	Process 1478 1493	hormone release
T39	Material 1515 1531	Cranial placodes
T40	Material 1569 1597	sensory and endocrine organs
T46	Material 1662 1678	cranial placodes
T47	Material 1684 1712	human pluripotent stem cells
T48	Material 1833 1851	mature lens fibers
T49	Material 1857 1881	anterior pituitary cells
T50	Material 1903 1920	human GH and ACTH
T51	Process 1978 2011	human cranial placode development
T3	Process 206 221	the dysfunction
T52	Material 225 248	placode-derived tissues
T35	Method 772 779	in vivo
T36	Process 780 791	engraftment
T54	Method 1494 1514	in vitro and in vivo
T55	Material 1745 1773	specific placode derivatives
